Victor Sandor - 24 Jun 2026 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Reporting relationship: Director
Issuer ticker: KYMR
Reported as of: 24 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2026, 18:00:04 UTC
Prior SEC filing: 10 Jun 2026
Next SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Bruce Jacobs, as Attorney-in-Fact

Key filing fact

Victor Sandor filed Form 4 for Kymera Therapeutics, Inc. (KYMR) on 25 Jun 2026.

Key facts

This page summarizes Victor Sandor's Form 4 filing for Kymera Therapeutics, Inc. (KYMR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2026, 18:00.

Change

Previous filing in this sequence was filed on 10 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001620368 Primary reporting owner

Sandor Victor

Relationship: Director
Address: C/O KYMERA THERAPEUTICS, INC., 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Signature date: 25 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KYMR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +6,068
Change %
Price: $0.000000^*
Shares after: 6,068
Date: 24 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,068
Exercise price: $99.87
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 24, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders.